0001209191-22-034385.txt : 20220603 0001209191-22-034385.hdr.sgml : 20220603 20220603201910 ACCESSION NUMBER: 0001209191-22-034385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220602 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chin Mark CENTRAL INDEX KEY: 0001734389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 22996460 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE, MAYFAIR CITY: LONDON STATE: X0 ZIP: W1J 6EQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMARA Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-206-2020 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-02 0 0001672619 IMARA Inc. IMRA 0001734389 Chin Mark C/O IMARA INC. 116 HUNTINGTON AVE, SIXTH FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 2344072 I By entities affiliated with Arix Bioscience plc Stock Options (Right to Buy) 1.07 2022-06-02 4 A 0 8500 0.00 A 2032-06-01 Common Stock 8500 8500 D The shares are directly beneficially owned by Arix Bioscience Holdings Limited ("Arix Ltd."). Arix Bioscience Plc ("Arix Plc") is the sole owner and parent of Arix Ltd. and may be deemed to indirectly beneficially own the shares held by Arix Ltd. Mr. Chin is a managing director of Arix plc. Each of Arix plc and Mr. Chin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein. The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant. /s/ Michael P. Gray, Attorney-in-Fact 2022-06-03